Navigation Links
Environmental factors in Tiny Tim's near fatal illness
Date:3/16/2012

Le Bonheur Professor Russell Chesney, M.D. believes he knows what was ailing Tiny Tim, the iconic character from Charles Dickens' "A Christmas Carol." Based on detailed descriptions of both the symptoms and living conditions of 18th century London, Dr. Chesney hypothesizes that Tiny Tim suffered from a combination of rickets and tuberculosis (TB). His findings were published in the March 5 edition of Archives of Pediatrics and Adolescent Medicine.

Dr. Chesney noted during the time the novel was written, 60 percent of children in London had rickets and nearly 50 percent displayed signs of TB. He says this is due to crowded living conditions, poor diets, filth and low exposure to sunlight. The coal-burning city of London in addition to particles from a Indonesian volcanic eruption contributed to blackened skies for many years.

Both rickets and TB can be improved and indeed cured through increased exposure to Vitamin D, which can be obtained through exposure to sunlight and a balanced diet.

As the Ghost of Christmas Present showed Ebenezer Scrooge, Tiny Tim's condition would be fatal without a different course for the boy. According to Dr. Chesney's research, Scrooge could have ensured an improved diet, sunshine exposure and cod liver oil (a common supplement of the day high in Vitamin D) through improved generosity to Bob Cratchit and his family.


'/>"/>
Contact: Sara Burnett
sara.burnett@lebonheur.org
901-287-5162
Le Bonheur Children's Hospital
Source:Eurekalert

Page: 1

Related biology news :

1. Reproductive health providers should discuss environmental exposure risks with patients
2. Effects of environmental toxicants reach down through generations
3. Can industrial parks be more environmentally friendly?
4. Research examines environmental triggers altering gene function in CFS patients
5. Environmental pollutant linked with overweight
6. Create effective new global environmental agency, ministers urged
7. Ocean microbe communities changing, but long-term environmental impact is unclear
8. NIST releases 2 new SRMs for monitoring human exposure to environmental toxins
9. GW researcher and colleagues identify environmental exposure to organochlorines may impact male reproduction
10. New EPA air quality rules outweigh costs and provide major health and environmental benefits
11. Study of Yellowstone wolves improves ability to predict their responses to environmental changes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/6/2017)... Forecasts by Product Type (EAC), Biometrics, Card-Based ... & Logistics, Government & Public Sector, Utilities / Energy ... Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality & ... for a definitive report on the $27.9bn Access Control ... ...
(Date:4/5/2017)... 2017 Today HYPR Corp. , leading ... component of the HYPR platform is officially FIDO® ... security architecture that empowers biometric authentication across Fortune 500 ... secured over 15 million users across the financial services ... home product suites and physical access represent a growing ...
(Date:4/4/2017)... 2017   EyeLock LLC , a leader of ... States Patent and Trademark Office (USPTO) has issued U.S. ... of an iris image with a face image acquired ... company,s 45 th issued patent. ... given the multi-modal biometric capabilities that have recently come ...
Breaking Biology News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Eli Lilly and ... 2 data evaluating galcanezumab for the prevention of migraine ... which will take place April 22-28, 2017, in ... present four abstracts at AAN, including safety and patient ... factors associated with a reduction in monthly migraine headache ...
(Date:4/20/2017)... Woburn, MA (PRWEB) , ... April 20, 2017 ... ... high brightness light sources for advanced technology applications, announced today that Chief Executive ... Board (NAAB). , SEMI is the global industry association connecting the ...
(Date:4/20/2017)... 2017 For today, Stock-Callers.com redirects investors, ... development and clinical research aimed at treating diseases and medical ... Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), Kite Pharma Inc. (NASDAQ: KITE), ... can access our complimentary research reports on these stocks now ... http://stock-callers.com/registration ...
(Date:4/19/2017)... ... 19, 2017 , ... Nobilis Therapeutics Announces Completion of Landmark NBTX-001 ... Data in its Upcoming Post Traumatic Stress Disorder Trial , Nobilis Therapeutics, Inc. ... assessing efficacy of its NBTX-001, a xenon-based therapeutic in the treatment of Panic Disorder. ...
Breaking Biology Technology: